Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biolane is a prominent French healthcare and dermo-pediatric company, widely recognized for its specialized baby care and hygiene products. Founded in 1972, the company operates as a flagship brand under the Havea Group and has established itself as a leader in the European pharmacy and mass-market sectors. Biolane's product development focuses on high-tolerance, natural-origin formulations designed for sensitive infant skin, incorporating proprietary technologies such as the Inubiom prebiotic complex to support the skin microbiome. The company's strategic importance was highlighted by the 2022 acquisition of Havea Group by BC Partners for approximately €1.1 billion, reflecting Biolane's strong market position and international growth potential in the consumer healthcare space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biolane.